학술논문
A SECOND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (HCT2) MAY CURE MORE THAN 40% PEDIATRIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Document Type
Abstract
Author
Source
In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S533-S533
Subject
Language
ISSN
2531-1379